1. Zhu JF, Yamane H, Paul WE (2010): Differentiation of effector CD4 T cell populations. Annu Rev Immunol 28: 445-489.
2.
Dong C (2008): TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 8: 337-348.
3.
Noack M, Miossec P (2014): Th17 and regulatory T cell balance in autoimmune and inflammatory diseases. Autoimmun Rev 13: 668-677.
4.
Kim JM, Rasmussen JP, Rudensky AY (2007): Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 8: 191-197.
5.
Curthoys NP, Watford M (1995): Regulation of glutaminase activity and glutamine metabolism. Annu Rev Nutr 15: 133-159.
6.
Nakaya M, Xiao YC, Zhou XF, et al. (2014): Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation. Immunity 40: 692-705.
7.
Wang RN, Dillon CP, Shi LZC, et al. (2011): The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity 35: 871-882.
8.
Carr EL, Kelman A, Wu GS, et al. (2010): Glutamine uptake and metabolism are coordinately regulated by ERK/MAPK during T lymphocyte activation. J Immunol 185: 1037-1044.
9.
Wang JB, Erickson JW, Fuji R, et al. (2010): Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell 18: 207-219.
10.
Siska PS, Kim B, Ji XM, et al. (2016): Fluorescence-based measurement of cystine uptake through xCT shows requirement for ROS detoxification in activated lymphocytes. J Immunol Methods 438: 51-58.
11.
Nakajima H, Kunimoto H (2014): TET2 as an epigenetic master regulator for normal and malignant hematopoiesis. Cancer Sci 105: 1093-1099.
12.
Zhu XT, Wang P, Zhan XX, et al. (2023): USP1-regulated reciprocal differentiation of Th17 cells and Treg cells by deubiquitinating and stabilizing TAZ. Cell Mol Immunol 20: 252-263.
13.
Bettelli E, Carrier Y, Gao WD, et al. (2006): Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
14.
Littman DR, Rudensky AY (2010): Th17 and regulatory T cells in mediating and restraining inflammation. Cell 140: 845-858.
15.
Ivanov II, McKenzie BS, Zhou L, et al. (2006): The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126: 1121-1133.
16.
Siska PJ, Kim B, Ji XM, et al. (2016): Fluorescence-based measurement of cystine uptake through xCT shows requirement for ROS detoxification in activated lymphocytes. J Immunol Methods 438: 51-58.
17.
Zhang L, Xu ZY, Li YJ, et al. (2024): Glutamine supplementation improves the activity and immunosuppressive action of induced regulatory T cells in vitro and in vivo. Transpl Immunol 84: 102044.
18.
Brescia C, Audia S, Pugliano A, et al. (2024): Metabolic drives affecting Th17/Treg gene expression changes and differentiation: impact on immune-microenvironment regulation. APMIS 132: 1026-1045.
19.
Sener Z, Cederkvist FH, Volchenkov R, et al. (2016): T helper cell activation and expansion is sensitive to glutaminase inhibition under both hypoxic and normoxic conditions. PLoS One 11: e0160291.
20.
Johnson MO, Wolf MM, Madden MZ, et al. (2018): Distinct regulation of Th17 and Th1 cell differentiation by glutaminase-dependent metabolism. Cell 175: 1780-1795.
21.
Xu T, Stewart KM, Wang XH, et al. (2017): Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism. Nature 548: 228-233.
22.
Wang ZF, Liu FY, Fan NB, et al. (2020): Targeting glutaminolysis: New perspectives to understand cancer development and novel strategies for potential target therapies. Front Oncol 10: 589508.
23.
Kono M, Yoshida N, Maeda K, et al. (2019): Glutaminase 1 inhibition reduces glycolysis and ameliorates lupus-like disease in MRL/lpr mice and experimental autoimmune encephalomyelitis. Arthritis Rheumatol 71: 1869-1878.
24.
Perl A (2013): Oxidative stress in the pathology and treatment of systemic lupus erythematosus. Nat Rev Rheumatol 9: 674-686.
